IFPG
ABBV icon

Intrepid Financial Planning Group’s AbbVie ABBV Stock Holding History

Intrepid Financial Planning Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Hold
1,079
– – 0.09% 112
2026
Q1 		$235K Hold
1,079
– – 0.09% 111
2025
Q4 		$247K Hold
1,079
– – 0.09% 104
2025
Q3 		$250K Buy
+1,079
New +$220K 0.1% 106

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Intrepid Financial Planning Group's ABBV Position: Q2 2026 in Review

Intrepid Financial Planning Group held its AbbVie (ABBV) position steady in Q2 2026 at 1,079 shares worth $272K. The position accounts for 0.09% of the portfolio, ranked #112.

Intrepid Financial Planning Group first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Intrepid Financial Planning Group held 1,079 shares of AbbVie worth $272K as of Q2 2026.
  • Intrepid Financial Planning Group left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.09% of Intrepid Financial Planning Group's portfolio in Q2 2026, its #112 holding.
  • Intrepid Financial Planning Group first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Intrepid Financial Planning Group's 13F filing for Q2 2026, filed 12 Aug 2026.